NBW: System, Test, Blood Glucose, Over The Counter

Product code NBW, “System, Test, Blood Glucose, Over The Counter” in FDA's classification database, is a Class II device type under 21 CFR 862.1345 (glucose test system), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 512 clearances under NBW, 281 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
NBW
Regulation
21 CFR 862.1345
Class
II
Panel
Clinical Chemistry
Clearances
512
Most recent
Oct 9, 2026
Median review, last 2 years
213 days
Third-party review
Not eligible
Implant
No

What it covers

A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.

The identification in 21 CFR 862.1345, glucose test system. FDA gives NBW no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K260687VivaChek Blood Glucose and ß-Ketone Dual BLE Monitoring System;VivaChek Blood Glucose and ß-Ketone Dual Monitoring System.Vivachek Biotech (Hangzhou) Co., Ltd.Oct 9, 2026Traditional
K260689CVS Advanced PLUS Blood Glucose Monitoring SystemI-Sens, Inc.Oct 2, 2026Special
K260545CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring System; CONTOUR® NEXT ONE Blood Glucose Monitoring SystemAscensia Diabetes CareAug 27, 2026Traditional
K262116TRUE METRIX Self Monitoring Blood Glucose SystemTrividia Health, Inc.Jul 23, 2026Special
K250085On Call® Sure GK Blood Glucose & Ketone Monitoring System; On Call® Sure Sync GK Blood Glucose & Ketone Monitoring SystemACON Laboratories, Inc.Oct 10, 2025Traditional
K243060TeleRPM Gen2 Blood Glucose Monitoring SystemGuangdong Transtek Medical Electronics Co., Ltd.Jan 30, 2025Traditional
K240637RIGHTEST Blood Glucose Monitoring System Max TelBionime CorporationNov 4, 2024Traditional
K240640Sejoy Blood Glucose Monitoring System; Sejoy Advance Link Blood Glucose Monitoring SystemSejoy Biomedical Co., Ltd.Oct 8, 2024Traditional
K241787CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring SystemAscensia Diabetes Care U.S., Inc.Aug 27, 2024Traditional
K222126VivaChek™ Fad Blood Glucose Monitoring System, VivaChek™ Fad Smart Blood Glucose Monitoring System, VivaChek™ Fad Sync Blood Glucose Monitoring SystemVivachek Biotech (Hangzhou) Co., Ltd.Aug 16, 2024Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 512 with a free account)

Clearances by year

281 NBW 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)4202
20252198
20247243
20235193
202212410
20217465
20207121
201910127
201819168
201725244
201620233
201532237
201424202
201347167
201230230
201130328

Who submits

91 applicants cleared a NBW device since 2011. 44% of the clearances went to applicants in United States, then Taiwan (30%), South Korea (12%) and China (11%). By type: Traditional 63% and Special 37%.

ApplicantClearances since 2011
Taidoc Technology Corporation20
I-Sens, Inc.19
Apex BioTechnology Corp.16
ACON Laboratories, Inc.11
Bionime Corporation11
Infopia Co, Ltd.10
Andon Health Co, Ltd.7
Andon Medical Co., Ltd.7

How FDA classifies it

Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

From 21 CFR 862.1345. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 862.1345 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent NBW clearances declared.

Ask about NBW

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about NBW

What is FDA product code NBW?

Product code NBW, “System, Test, Blood Glucose, Over The Counter” in FDA's classification database, is a Class II device type under 21 CFR 862.1345 (glucose test system), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 512 clearances under NBW, 281 of them since 2011.

How many 510(k) clearances are there under NBW?

FDA’s 510(k) database listed 512 clearances under NBW as of Oct 29, 2026, 281 of them decided since 2011; the most recent decision was Oct 9, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a NBW 510(k)?

For the 7 NBW clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 213 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most NBW clearances?

Since 2011: Taidoc Technology Corporation (20), I-Sens, Inc. (19), Apex BioTechnology Corp. (16), ACON Laboratories, Inc. (11) and Bionime Corporation (11). 91 applicants have cleared a NBW device in that time.

Sources

  1. FDA product classification: NBW · Product Classification database
  2. 21 CFR 862.1345: Glucose test system · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for NBW · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow NBWGet an email when FDA clears, recalls or publishes guidance for NBW devices.

Know what FDA already cleared.